Listed by the USPTO as STEELE, AMBER D
Tech Center 1600 • Art Units: 1627 1639 1645 1654 1658 1676
This examiner grants 59% of resolved cases
STEELE, AMBER D works in USPTO Technology Center 1600, Art Unit 1627. The profile contains 829 resolved cases, an allowance rate of 58.9%, and a median of 1253 days to allowance. Interview lift is 9.3%, indicating a modest associated improvement in a record with moderate allowance performance and extended timing.
The listed companies are Mayo Foundation for Medical Education and Research, The Regents of the University of Michigan, and Henkel AG & Co. KGaA. The leading firms are FOLEY & LARDNER LLP, MYERS BIGEL, P.A., and Apex Attorneys at Law, LLP. Practitioners should plan around the median duration and use interviews as a supporting rather than dominant strategy.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17778306 | POLYPEPTIDE INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY AND USES THEREOF | Non-Final OA | The Regents of the University of Michigan |
| 18404131 | MANP Analogues | Non-Final OA | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH |
| 17768537 | Bi-Peptide with Affinity to Extracellular Matrix Proteins or Cells and to Growth Factors for Tissue Healing and Regeneration | Final Rejection | Mayo Foundation for Medical Education and Research |
| 18564739 | Substrate-specific adhesive peptides | Final Rejection | HENKEL AG & CO. KGAA |
| 18265523 | SCG2 NEUROPEPTIDES AND USES THEREOF | Final Rejection | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 17760668 | Conformationally-Constrained Alpha-RGIA Analogues | Final Rejection | University of Utah Research Foundation |
| 18037098 | VIBRIO TOXIN BINDING PROTEINS IN SHRIMP AND USES THEREOF | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA |
| 18872790 | PREVENTING ALU SINES-MEDIATED PATHOLOGIES | Non-Final OA | UNIVERSITY OF SOUTH FLORIDA |
| 18290872 | ANTI-FUNGAL GRIFFITHSIN COMPOSITIONS AND METHODS OF USE | Non-Final OA | University of Louisville Research Foundation, Inc. |
| 16632226 | COMPOSITIONS AND METHODS COMPRISING SELF-ASSEMBLING PEPTIDE-POLYMER NANOFIBERS FOR SUBLINGUAL IMMUNIZATION | Non-Final OA | Duke University |
| 18290214 | Engineered Antimicrobial Peptides and Usage Thereof | Final Rejection | Peptilogics, Inc. |
| 18439838 | FUNTIONALLY MODIFIED POLYPEPTIDES AND RADIOBIOSYNTHESIS | Final Rejection | RATIO THERAPEUTICS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy58.9% of resolved applications examined by Amber D Steele were allowed (829 resolved cases), compared with 35.1% across Art Unit 1627 over the last five years.
This examiner's interview lift is +9.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Amber D Steele took 1,253 days on average from filing to allowance.
Amber D Steele examines applications in Art Unit 1627 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
